Manuscripts

Review our scientific manuscripts in oncology and rheumatology.

2018-2020

ON THIS PAGE: Oncology | Rheumatology

Oncology

Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States. Ann Hematol. 2020 Nov;99(11):2555-2564. doi: 10.1007/s00277-020-04055-w. Epub 2020 May 7.

Verstovsek S, Yu J, Kish JK, Paranagama D, Kaufman J, Myerscough C, Grunwald MR, Colucci P, Mesa R.

Available upon request.

Use of Real-World Evidence to Support FDA Approval of Oncology Drugs. Value Health. 2020 Oct;23(10):1358-1365. doi: 10.1016/j.jval.2020.06.006. Epub 2020 Sep 14.

Feinberg BA, Gajra A, Zettler ME, Phillips TD, Phillips EG Jr, Kish JK.

Available upon request.

Care Coordination Between Prescribers and the Specialty Pharmacy for Multiple Myeloma: Qualitative Insights Into Designing a Quality Improvement Program for Multisite Community Oncology Practices. J Clin Pathways. 2020;6(6):43-48. doi:10.25270/jcp.2020.8.00002.

McCullough SW, Blaisdell D, Kish JK, Laney J, Valuck T, Dickson N, Berdeja JG, Patton JF, Copher R, Powers A.

Read the manuscript

Physician treatment of metastatic triple-negative breast cancer in the immuno-oncology era: a discrete choice experiment. Future Oncol. 2020 Sep 21. doi: 10.2217/fon-2020-0729. Online ahead of print.

Feinberg B, Hime S, Wojtynek J, Dokubo I, Gajra A, Smith Y, Kish J.

Read the manuscript

Neurological adverse events following CAR T-cell therapy: a real-world analysis. Immunotherapy. 2020 Oct;12(14):1077-1082. doi: 10.2217/imt-2020-0161. Epub 2020 Aug 18.

Gajra A, Zettler ME, Phillips EG Jr, Klink AJ, Jonathan K Kish, Fortier S, Mehta S, Feinberg BA.

Available upon request.

Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years. J Geriatr Oncol. 2020 Aug 11:S1879-4068(20)30145-4. doi: 10.1016/j.jgo.2020.07.006. Online ahead of print.

Zettler ME, Feinberg BA, Phillips EG Jr, Klink AJ, Mehta S, Gajra A.

Available upon request.

Making the case for EGFR TKI sequencing in EGFR mutation-positive NSCLC: a GioTag study US patient analysis. Future Oncol. 2020 Aug;16(22):1585-1595. doi: 10.2217/fon-2020-0188. Epub 2020 Aug 6.

Feinberg B, Halmos B, Gucalp R, Tang W, Moehring B, Hochmair MJ.

Read the manuscript

Randomization versus Real-World Evidence. N Engl J Med. 2020 Jul 23;383(4):e21. doi: 10.1056/NEJMc2020020.

Gajra A, Zettler ME, Feinberg BA.

Available upon request.

Perceptions of community hematologists/oncologists on barriers to chimeric antigen receptor T-cell therapy for the treatment of diffuse large B-cell lymphoma. Immunotherapy. 2020 Jul;12(10):725-732. doi: 10.2217/imt-2020-0118. Epub 2020 Jun 18.

Gajra A, Jeune-Smith Y, Kish J, Yeh TC, Hime S, Feinberg B.

Read the manuscript

Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States. Adv Ther. 2020 Jun;37(6):2841-2852. doi: 10.1007/s12325-020-01362-6. Epub 2020 May 7.

Kish JK, Chatterjee D, Wan Y, Yu HT, Liassou D, Feinberg BA.

Read the manuscript

Frequency and Causes of Burnout in US Community Oncologists in the Era of Electronic Health Records. JCO Oncol Pract. 2020 Apr;16(4):e357-e365. doi: 10.1200/JOP.19.00542.

Gajra A, Bapat B, Jeune-Smith Y, Nabhan C, Klink AJ, Liassou D, Mehta S, Feinberg B.

Available upon request.

The Role and Scope of Practice of Advanced Practice Providers in United States Community Oncology. J Clin Pathways. 2020;6(3):36-41. doi:10.25270/jcp.2020.4.00001.

Gajra A, Nabhan C, Klink AJ, Yeh T, Bapat B, Smith YJ, Feinberg BA.

Read the manuscript

A Letter in Support of Real-World RECIST. Adv Ther. 2020 Apr;37(4):1688-1690. doi: 10.1007/s12325-020-01245-w. Epub 2020 Feb 13.

Gajra A, Feinberg BA.

Read the manuscript

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis. Oncologist. 2020 Apr;25(4):319-326. doi: 10.1634/theoncologist.2019-0699. Epub 2020 Jan 17.

Feinberg B, Kish J, Dokubo I, Wojtynek J, Gajra A, Lord K.

Read the manuscript

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States. J Clin Pathways. 2020;6(1):44-53. doi:10.25270/jcp.2020.2.00112.

Klink AJ, Nabhan C, Lee CH, Laney J, Yang Y, Purdum AG, Feinberg BA.

Read the manuscript

Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancer. Future Oncol. 2020 Jan;16(1):4303-4313. doi: 10.2217/fon-2019-0524. Epub 2019 Dec 5.

Ryan KJ, Nero D, Feinberg BA, Lee CH, Pimentel R, Gajra A, Kish JK, Seal B.

Read the manuscript

Observational study of clinical outcomes of eribulin mesylate in metastatic breast cancer after cyclin-dependent kinase 4/6 inhibitor therapy. Future Oncol. 2019 Dec;15(34):3935-3944. doi: 10.2217/fon-2019-0537. Epub 2019 Oct 29.

Mougalian SS, Feinberg BA, Wang E, Alexis K, Chatterjee D, Knoth RL, Nero D, Miller T, Liassou D, Kish JK.

Read the manuscript

Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents. J Med Econ. 2020 Feb;23(2):125-131. doi: 10.1080/13696998.2019.1676760. Epub 2019 Oct 18.

Abraham P, Kish JK, Korytowsky B, Radtchenko J, Singh P, Shaw J, Feinberg B.

Available upon request.

Reports of the demise of chemotherapy have been greatly exaggerated. Am J Manag Care. 2019 Jun;25(6):270-272.

Feinberg B, Kish J, Dokubo I, Wojtynek J, Lord K.

Read the manuscript

Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine Tumors. Oncologist. 2019 Oct;24(10):1331-1339. doi: 10.1634/theoncologist.2018-0798. Epub 2019 Apr 23.

Klink AJ, Feinberg B, Yu HT, Ray D, Pulgar S, Phan A, Vinik A.

Read the manuscript

Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United States. J Manag Care Spec Pharm. 2019 Aug;25(8):869-877. doi: 10.18553/jmcp.2019.18442. Epub 2019 Apr 4.

Klink AJ, Chmielowski B, Feinberg B, Ahsan S, Nero D, Liu FX.

Available upon request.

Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomiting. J Comp Eff Res. 2019 Jul;8(9):657-670. doi: 10.2217/cer-2018-0104. Epub 2019 May 9.

Schwartzberg LS, Marks SM, Gabrail NY, Geller RB, Kish J.

Available upon request.

Surrogate End Points and Patient-Reported Outcomes for Novel Oncology Drugs Approved Between 2011 and 2017. JAMA Oncol. 2019 Jul 3;5(9):1358-9. doi: 10.1001/jamaoncol.2019.1760.

Zettler M, Basch E, Nabhan C.

Read the manuscript

Real-world Evidence-What Does It Really Mean? JAMA Oncol. 2019 Jun 1;5(6):781-783. doi: 10.1001/jamaoncol.2019.0450.

Nabhan C, Klink A, Prasad V.

Available upon request.

Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study. Future Oncol. 2019 Sep 1;15(25):2933-2942. doi: 10.2217/fon-2018-0964. Epub 2019 Feb 25.

Luke JJ, Ghate SR, Kish J, Lee CH, McAllister L, Mehta S, Ndife B, Feinberg BA.

Available upon request.

Read the manuscript

The gamification of healthcare: emergence of the digital practitioner? Am J Manag Care. 2019 Jan;25(1):13-15.

Phillips EG Jr, Nabhan C, Feinberg BA.

Read the manuscript

Acute myeloid leukemia in the elderly: what constitutes treatment value? Leuk Lymphoma. 2019 May;60(5):1164-1170. doi: 10.1080/10428194.2018.1520992.

Nabhan C, Kamat S, Karl Kish J.

Available upon request.

Value in Oncology: It Is in the Eyes of the Beholder. J Natl Compr Canc Netw. 2019 Jan;17(1):2-5. doi: 10.6004/jnccn.2018.7092.

Nabhan C, Phillips EG, Feinberg BA.

Available upon request.

Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes. Leuk Lymphoma. 2019 Aug;60(8):2050-2055. doi: 10.1080/10428194.2018.1551538. Epub 2019 Jan 14.

Zeidan AM, Klink AJ, McGuire M, Feinberg B.

Available upon request.

Orphan Cancer Drugs in the Era of Precision Medicine. JAMA Oncol. 2018 Nov 1;4(11):1481-1482. doi: 10.1001/jamaoncol.2018.3498.

Nabhan C, Phillips EG Jr, Feinberg BA.

Available upon request.

Understanding total cost of care in advanced non-small cell lung cancer pre- and postapproval of immuno-oncology therapies. Am J Manag Care. 2018 Oct;24(20 Suppl):S439-S447.

Korytowsky B, Radtchenko J, Nwokeji ED, Tuell KW, Kish JK, Feinberg BA.

Read the manuscript

How Pharmacy Benefit Managers Add to Financial Toxicity: The Copay Accumulator Program. JAMA Oncol. 2018 Dec 1;4(12):1665-1666. doi: 10.1001/jamaoncol.2018.4554.

Nabhan C, Phillips EG Jr, Feinberg BA.

Available upon request.

Clinical benefit of treatment with eribulin mesylate for metastatic triple-negative breast cancer: Long-term outcomes of patients treated in the US community oncology setting. Cancer Med. 2018 Sep;7(9):4371-4378. doi: 10.1002/cam4.1705. Epub 2018 Jul 31.

Mougalian SS, Copher R, Kish JK, McAllister L, Wang Z, Broscious M, Garofalo D, Radtchenko J, Feinberg BA.

Read the manuscript

Barriers to Oncology Biosimilars Uptake in the United States. Oncologist. 2018 Nov;23(11):1261-1265. doi: 10.1634/theoncologist.2018-0066. Epub 2018 Jul 26.

Nabhan C, Valley A, Feinberg BA.

Read the manuscript

Using Response Evaluation Criteria in Solid Tumors in real-world evidence cancer research. Future Oncol. 2018 Nov;14(27):2841-2848. doi: 10.2217/fon-2018-0317. Epub 2018 May 31.

Feinberg BA, Bharmal M, Klink AJ, Nabhan C, Phatak H.

Available upon request.

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer. J Clin Pathways. 2018;4(6):40-47. doi:10.25270/jcp.2018.08.00029.

Christodoulopoulou A, Bach BA, Klink AJ, Hechmati G, Mujumdar U, Feinberg BA, Fakih M.

Read the manuscript

CAR-T Therapies: Placing Patient Safety First. J Clin Pathways. 2018;4(6):38-39. doi:10.25270/jcp.2018.08.00028.

Nabhan C, Feinberg BA.

Read the manuscript

Fulfillment of Postmarketing Requirements to the FDA for Therapies Granted Oncology Indications Between 2011 and 2016. JAMA Oncol. 2018 Jul 1;4(7):993-994. doi: 10.1001/jamaoncol.2018.0610.

Zettler M, Nabhan C.

Read the manuscript

Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval. Breast Cancer Res. 2018 May 2;20(1):37. doi: 10.1186/s13058-018-0958-2.

Kish JK, Ward MA, Garofalo D, Ahmed HV, McRoy L, Laney J, Zanotti G, Braverman J, Yu H, Feinberg BA.

Read the manuscript

Understanding Provider Perceptions Is Key to Utilization and Uptake of CAR-T Therapy. J Clin Pathways. 2018;4(3):39-40. doi:10.25270/jcp.2018.04.00010.

Nabhan C, Feinberg BA.

Read the manuscript

Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment Program. JAMA Oncol. 2018 Feb 1;4(2):252-253. doi: 10.1001/jamaoncol.2017.3773.

Nabhan C, Jeune-Smith Y, Klinefelter P, Kelly RJ, Feinberg BA.

Read the manuscript

Biosimilars in Oncology in the United States: A Review. JAMA Oncol. 2018 Feb 1;4(2):241-247. doi: 10.1001/jamaoncol.2017.2004.

Nabhan C, Parsad S, Mato AR, Feinberg BA.

Available upon request.

Community Oncologists' Perception and Acceptance of Biosimilars in Oncology. J Clin Pathways. 2018;4(2):43-47. doi:10.25270/jcp.2018.03.00005.

Nabhan C, MD, Jeune-Smith Y, Valley A, Feinberg BA.

Read the manuscript

Mock Clinical Pathways: Exploring the Process of Developing a Pathway for Metastatic Breast Cancer. J Clin Pathways. 2018:4(1):56-61. doi:10.25270/jcp.2018.02.00002

Nabhan C, Feinberg BA.

Read the manuscript

Rheumatology

Real-world outcomes among patients with early rapidly progressive rheumatoid arthritis. Am J Manag Care. 2019 Oct 1;25(10):e288-e295.

Klink AJ, Curtice TG, Gupta K, Tuell KW, Szymialis AR, Nero D, Feinberg BA.

Read the manuscript